Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	FRAS1 COL12A1 FN1 COL6A6 AEBP1 MUC17 PRG4 MUC3A	5.24e-07	188	75	8	GO:0005201
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A	8.31e-05	4	75	2	GO:0030197
GeneOntologyMolecularFunction	structural molecule activity	CYLC1 FRAS1 COL12A1 FN1 MYOM1 COL6A6 AEBP1 MUC17 PRG4 MUC3A MYBPC1	4.71e-04	891	75	11	GO:0005198
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO2 NOMO3 NOMO1	3.52e-06	9	73	3	GO:0160063
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CADM3 PRTG FAT4 PCDHGB6 PCDHGB3 FAT3 PLXNB3	4.42e-06	187	73	7	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CADM3 NRG1 PRTG FAT4 PCDHGB6 PCDHGB3 FAT3 PLXNB3	1.47e-05	313	73	8	GO:0098742
GeneOntologyBiologicalProcess	neuron projection development	NRG1 DLG5 PRTG FAT4 FN1 RNF6 NCKAP1 FAT3 SEMA6A FGFR3 RAB6B RAB6A PLXNA2 PLXNB3 CRK	3.61e-05	1285	73	15	GO:0031175
GeneOntologyBiologicalProcess	regulation of neuron migration	IGSF10 NRG1 SEMA6A ARHGEF2	6.90e-05	62	73	4	GO:2001222
GeneOntologyBiologicalProcess	protein localization to Golgi membrane	RAB6B RAB6A	1.23e-04	5	73	2	GO:1903292
GeneOntologyBiologicalProcess	neuron migration	IGSF10 NRG1 FAT3 SEMA6A ARHGEF2 CRK	1.23e-04	218	73	6	GO:0001764
GeneOntologyBiologicalProcess	neuron development	NRG1 DLG5 PRTG FAT4 FN1 RNF6 NCKAP1 FAT3 SEMA6A FGFR3 RAB6B RAB6A PLXNA2 PLXNB3 CRK	1.56e-04	1463	73	15	GO:0048666
GeneOntologyBiologicalProcess	protein insertion into ER membrane	NOMO2 NOMO3 NOMO1	1.78e-04	31	73	3	GO:0045048
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO3 NOMO1	3.67e-06	9	75	3	GO:0160064
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO2 NOMO3 NOMO1	1.57e-05	14	75	3	GO:0072379
GeneOntologyCellularComponent	collagen-containing extracellular matrix	FRAS1 COL12A1 FN1 COL6A6 AEBP1 MUC17 COL20A1 PRG4 PLXNA2	1.15e-04	530	75	9	GO:0062023
GeneOntologyCellularComponent	extracellular matrix	FRAS1 COL12A1 FN1 COL6A6 AEBP1 MUC17 COL20A1 PRG4 PLXNA2	5.53e-04	656	75	9	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	FRAS1 COL12A1 FN1 COL6A6 AEBP1 MUC17 COL20A1 PRG4 PLXNA2	5.66e-04	658	75	9	GO:0030312
GeneOntologyCellularComponent	semaphorin receptor complex	PLXNA2 PLXNB3	9.66e-04	13	75	2	GO:0002116
Domain	Ig-like_fold	IGSF10 CADM3 NRG1 ICOSLG MFAP3 PRTG COL12A1 FN1 MYOM1 NOMO2 COL20A1 FGFR3 PLXNA2 NOMO3 PLXNB3 MYBPC1 NOMO1	1.66e-09	706	74	17	IPR013783
Domain	-	IGSF10 CADM3 NRG1 MFAP3 PRTG COL12A1 FN1 MYOM1 NOMO2 COL20A1 FGFR3 PLXNA2 NOMO3 PLXNB3 MYBPC1 NOMO1	5.26e-09	663	74	16	2.60.40.10
Domain	CarboxyPept_regulatory_dom	AEBP1 NOMO2 NOMO3 NOMO1	1.58e-07	13	74	4	IPR014766
Domain	-	AEBP1 NOMO2 NOMO3 NOMO1	1.58e-07	13	74	4	2.60.40.1120
Domain	DUF2012	NOMO2 NOMO3 NOMO1	2.38e-07	4	74	3	PF09430
Domain	DUF2012	NOMO2 NOMO3 NOMO1	2.38e-07	4	74	3	IPR019008
Domain	CarboxyPept-like_regulatory	AEBP1 NOMO2 NOMO3 NOMO1	5.20e-07	17	74	4	IPR008969
Domain	Ig_I-set	IGSF10 CADM3 NRG1 MFAP3 PRTG MYOM1 FGFR3 MYBPC1	8.41e-07	190	74	8	IPR013098
Domain	I-set	IGSF10 CADM3 NRG1 MFAP3 PRTG MYOM1 FGFR3 MYBPC1	8.41e-07	190	74	8	PF07679
Domain	Carb-bd-like_fold	NOMO2 NOMO3 NOMO1	3.30e-06	8	74	3	IPR013784
Domain	IGc2	IGSF10 CADM3 NRG1 MFAP3 PRTG MYOM1 FGFR3 MYBPC1	4.11e-06	235	74	8	SM00408
Domain	Ig_sub2	IGSF10 CADM3 NRG1 MFAP3 PRTG MYOM1 FGFR3 MYBPC1	4.11e-06	235	74	8	IPR003598
Domain	SEA	MUC17 MUC16 MUC3A	2.11e-05	14	74	3	SM00200
Domain	IG	IGSF10 CADM3 NRG1 ICOSLG MFAP3 PRTG MYOM1 FGFR3 MYBPC1	4.17e-05	421	74	9	SM00409
Domain	Ig_sub	IGSF10 CADM3 NRG1 ICOSLG MFAP3 PRTG MYOM1 FGFR3 MYBPC1	4.17e-05	421	74	9	IPR003599
Domain	fn3	PRTG COL12A1 FN1 MYOM1 COL20A1 MYBPC1	4.42e-05	162	74	6	PF00041
Domain	Laminin_G	FAT4 COL12A1 COL20A1 FAT3	8.19e-05	58	74	4	IPR001791
Domain	FN3	PRTG COL12A1 FN1 MYOM1 COL20A1 MYBPC1	9.23e-05	185	74	6	SM00060
Domain	SEA	MUC17 MUC16 MUC3A	9.99e-05	23	74	3	PS50024
Domain	SEA_dom	MUC17 MUC16 MUC3A	9.99e-05	23	74	3	IPR000082
Domain	IG_LIKE	IGSF10 CADM3 NRG1 ICOSLG MFAP3 PRTG MYOM1 FGFR3 MYBPC1	1.35e-04	491	74	9	PS50835
Domain	FN3	PRTG COL12A1 FN1 MYOM1 COL20A1 MYBPC1	1.38e-04	199	74	6	PS50853
Domain	Ig-like_dom	IGSF10 CADM3 NRG1 ICOSLG MFAP3 PRTG MYOM1 FGFR3 MYBPC1	1.62e-04	503	74	9	IPR007110
Domain	FN3_dom	PRTG COL12A1 FN1 MYOM1 COL20A1 MYBPC1	1.80e-04	209	74	6	IPR003961
Domain	Sema	SEMA6A PLXNA2 PLXNB3	2.48e-04	31	74	3	SM00630
Domain	Semap_dom	SEMA6A PLXNA2 PLXNB3	2.48e-04	31	74	3	IPR001627
Domain	Sema	SEMA6A PLXNA2 PLXNB3	2.48e-04	31	74	3	PF01403
Domain	SEMA	SEMA6A PLXNA2 PLXNB3	2.48e-04	31	74	3	PS51004
Domain	PSI	SEMA6A PLXNA2 PLXNB3	2.73e-04	32	74	3	PF01437
Domain	Plexin_repeat	SEMA6A PLXNA2 PLXNB3	2.73e-04	32	74	3	IPR002165
Domain	EGF	NRG1 FAT4 FRAS1 MUC17 FAT3 MUC3A	3.38e-04	235	74	6	SM00181
Domain	EGF-like_dom	NRG1 FAT4 FRAS1 MUC17 FAT3 MUC3A	4.59e-04	249	74	6	IPR000742
Domain	EGF_1	NRG1 FAT4 FN1 MUC17 FAT3 MUC3A	5.21e-04	255	74	6	PS00022
Domain	Plexin_cytopl	PLXNA2 PLXNB3	5.48e-04	9	74	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA2 PLXNB3	5.48e-04	9	74	2	IPR013548
Domain	Plexin	PLXNA2 PLXNB3	5.48e-04	9	74	2	IPR031148
Domain	EGF-like_CS	NRG1 FAT4 FN1 MUC17 FAT3 MUC3A	5.88e-04	261	74	6	IPR013032
Domain	PSI	SEMA6A PLXNA2 PLXNB3	7.04e-04	44	74	3	IPR016201
Domain	PSI	SEMA6A PLXNA2 PLXNB3	8.02e-04	46	74	3	SM00423
Domain	Cadherin_CS	FAT4 PCDHGB6 PCDHGB3 FAT3	9.23e-04	109	74	4	IPR020894
Domain	CADHERIN_1	FAT4 PCDHGB6 PCDHGB3 FAT3	1.06e-03	113	74	4	PS00232
Domain	Cadherin	FAT4 PCDHGB6 PCDHGB3 FAT3	1.06e-03	113	74	4	PF00028
Domain	CADHERIN_2	FAT4 PCDHGB6 PCDHGB3 FAT3	1.09e-03	114	74	4	PS50268
Domain	-	FAT4 PCDHGB6 PCDHGB3 FAT3	1.09e-03	114	74	4	2.60.40.60
Domain	CA	FAT4 PCDHGB6 PCDHGB3 FAT3	1.13e-03	115	74	4	SM00112
Domain	Cadherin-like	FAT4 PCDHGB6 PCDHGB3 FAT3	1.16e-03	116	74	4	IPR015919
Domain	Cadherin	FAT4 PCDHGB6 PCDHGB3 FAT3	1.24e-03	118	74	4	IPR002126
Domain	VWA	COL12A1 COL6A6 COL20A1	1.42e-03	56	74	3	PF00092
Domain	-	MUC17 MUC16	1.57e-03	15	74	2	3.30.70.960
Domain	EGF_3	NRG1 FAT4 MUC17 FAT3 MUC3A	2.41e-03	235	74	5	PS50026
Domain	-	COL12A1 COL6A6 COL20A1	3.16e-03	74	74	3	3.40.50.410
Domain	SEA	MUC17 MUC16	3.40e-03	22	74	2	PF01390
Domain	TSPN	COL12A1 COL20A1	3.71e-03	23	74	2	SM00210
Domain	EGF_2	NRG1 FAT4 MUC17 FAT3 MUC3A	4.02e-03	265	74	5	PS01186
Domain	tRNA-bd_arm	RPRD2 FYCO1	4.04e-03	24	74	2	IPR010978
Domain	VWFA	COL12A1 COL6A6 COL20A1	4.23e-03	82	74	3	PS50234
Domain	VWA	COL12A1 COL6A6 COL20A1	4.52e-03	84	74	3	SM00327
Domain	Collagen	COL12A1 COL6A6 COL20A1	4.67e-03	85	74	3	IPR008160
Domain	Collagen	COL12A1 COL6A6 COL20A1	4.67e-03	85	74	3	PF01391
Domain	IPT	PLXNA2 PLXNB3	5.10e-03	27	74	2	SM00429
Domain	-	FAT4 COL12A1 FAT3	6.37e-03	95	74	3	2.60.120.200
Domain	TIG	PLXNA2 PLXNB3	6.69e-03	31	74	2	PF01833
Domain	ig	NRG1 MFAP3 MYOM1 FGFR3	6.86e-03	190	74	4	PF00047
Domain	Immunoglobulin	NRG1 MFAP3 MYOM1 FGFR3	6.86e-03	190	74	4	IPR013151
Domain	IPT	PLXNA2 PLXNB3	7.11e-03	32	74	2	IPR002909
Domain	VWF_A	COL12A1 COL6A6 COL20A1	7.13e-03	99	74	3	IPR002035
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC17 MUC16 MUC3A	3.04e-05	16	55	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC17 MUC16 MUC3A	3.68e-05	17	55	3	M27412
Pathway	REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	SEMA6A PLXNA2 PLXNB3	5.21e-05	19	55	3	M10959
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC17 MUC16 MUC3A	9.42e-05	23	55	3	M556
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC17 MUC16 GALNT12 MUC3A	9.78e-05	62	55	4	M546
Pathway	REACTOME_DECTIN_2_FAMILY	MUC17 MUC16 MUC3A	1.37e-04	26	55	3	M27483
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC17 MUC16 GALNT12 MUC3A	1.40e-04	68	55	4	M27303
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO3 NOMO1	1.00e-08	3	76	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO3 NOMO1	1.00e-08	3	76	3	25576386
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO3 NOMO1	4.00e-08	4	76	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO3 NOMO1	4.00e-08	4	76	3	9267806
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO2 NOMO3 NOMO1	5.57e-07	8	76	3	15257293
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO2 NOMO3 NOMO1	8.34e-07	9	76	3	36261522
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO2 NOMO3 NOMO1	1.63e-06	11	76	3	32820719
Pubmed	Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina.	SEMA6A PLXNA2 PLXNB3	2.17e-06	12	76	3	21270798
Pubmed	Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration.	FGFR3 TACC3	4.71e-06	2	76	2	32199932
Pubmed	Rab6-Mediated Polarized Transport of Synaptic Vesicle Precursors Is Essential for the Establishment of Neuronal Polarity and Brain Formation.	RAB6B RAB6A	4.71e-06	2	76	2	38830762
Pubmed	Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients.	FGFR3 TACC3	4.71e-06	2	76	2	28838400
Pubmed	FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium.	FGFR3 TACC3	4.71e-06	2	76	2	29991799
Pubmed	Time-lapse analysis of tangential migration in Sema6A and PlexinA2 knockouts.	SEMA6A PLXNA2	4.71e-06	2	76	2	25284064
Pubmed	Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability.	FGFR3 TACC3	4.71e-06	2	76	2	36780330
Pubmed	Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.	FGFR3 TACC3	4.71e-06	2	76	2	25294908
Pubmed	Plexin-A2 and its ligand, Sema6A, control nucleus-centrosome coupling in migrating granule cells.	SEMA6A PLXNA2	4.71e-06	2	76	2	18327254
Pubmed	Structural basis for semaphorin signalling through the plexin receptor.	SEMA6A PLXNA2	4.71e-06	2	76	2	20881961
Pubmed	Non-Small Cell Lung Carcinoma With Clear Cell Features and FGFR3::TACC3 Gene Rearrangement : Clinicopathologic and Next Generation Sequencing Study of 7 Cases.	FGFR3 TACC3	4.71e-06	2	76	2	38084010
Pubmed	Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.	FGFR3 TACC3	4.71e-06	2	76	2	32384449
Pubmed	Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma.	FGFR3 TACC3	4.71e-06	2	76	2	25535896
Pubmed	Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions.	FGFR3 TACC3	4.71e-06	2	76	2	32413119
Pubmed	Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation.	FGFR3 TACC3	4.71e-06	2	76	2	26869289
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC17 MUC16 MUC3A	7.99e-06	18	76	3	18834073
Pubmed	Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers.	SEMA6A PLXNA2	1.41e-05	3	76	2	17296555
Pubmed	Rab6 family proteins interact with the dynein light chain protein DYNLRB1.	RAB6B RAB6A	1.41e-05	3	76	2	18044744
Pubmed	Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.	SEMA6A PLXNA2	1.41e-05	3	76	2	22777942
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC17 MUC3A	1.41e-05	3	76	2	10512748
Pubmed	Cohen syndrome-associated protein COH1 physically and functionally interacts with the small GTPase RAB6 at the Golgi complex and directs neurite outgrowth.	RAB6B RAB6A	1.41e-05	3	76	2	25492866
Pubmed	O-GlcNAc modification affects the ATM-mediated DNA damage response.	OGT ATM	1.41e-05	3	76	2	22759405
Pubmed	The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.	FGFR3 TACC3	1.41e-05	3	76	2	23298836
Pubmed	Oncogenic FGFR3 gene fusions in bladder cancer.	FGFR3 TACC3	1.41e-05	3	76	2	23175443
Pubmed	A novel 4p16.3 microduplication distal to WHSC1 and WHSC2 characterized by oligonucleotide array with new phenotypic features.	FGFR3 TACC3	1.41e-05	3	76	2	21815251
Pubmed	A new Mint1 isoform, but not the conventional Mint1, interacts with the small GTPase Rab6.	RAB6B RAB6A	1.41e-05	3	76	2	23737971
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	FAT4 NCKAP1 FAT3 NOMO3	1.45e-05	67	76	4	21875946
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	COL12A1 FN1 COL6A6 AEBP1 PRG4	2.22e-05	153	76	5	25037231
Pubmed	Transforming fusions of FGFR and TACC genes in human glioblastoma.	FGFR3 TACC3	2.82e-05	4	76	2	22837387
Pubmed	Structural basis of semaphorin-plexin signalling.	SEMA6A PLXNA2	2.82e-05	4	76	2	20877282
Pubmed	The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines.	FGFR3 TACC3	2.82e-05	4	76	2	10366448
Pubmed	Structure of the Human TELO2-TTI1-TTI2 Complex.	TELO2 ATM	2.82e-05	4	76	2	34838521
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	NOMO2 NOMO3 NOMO1	4.31e-05	31	76	3	19136429
Pubmed	Guidance-cue control of horizontal cell morphology, lamination, and synapse formation in the mammalian outer retina.	SEMA6A PLXNA2	4.69e-05	5	76	2	22593055
Pubmed	Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport.	RAB6B RAB6A	4.69e-05	5	76	2	11929610
Pubmed	ELKS1 Captures Rab6-Marked Vesicular Cargo in Presynaptic Nerve Terminals.	RAB6B RAB6A	4.69e-05	5	76	2	32521280
Pubmed	An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.	NOMO2 NOMO3 NOMO1	5.22e-05	33	76	3	30783098
Pubmed	Semaphorin-Plexin signaling influences early ventral telencephalic development and thalamocortical axon guidance.	SEMA6A PLXNA2	7.03e-05	6	76	2	28438183
Pubmed	Roles of semaphorin-6B and plexin-A2 in lamina-restricted projection of hippocampal mossy fibers.	SEMA6A PLXNA2	7.03e-05	6	76	2	20484647
Pubmed	PlexinA2 and Sema6A are required for retinal progenitor cell migration.	SEMA6A PLXNA2	7.03e-05	6	76	2	27301906
Pubmed	A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.	FGFR3 TACC3	7.03e-05	6	76	2	20348956
Pubmed	The addition of 5'-coding information to a 3'-directed cDNA library improves analysis of gene expression.	OGT NOMO3 NOMO1	7.39e-05	37	76	3	8076819
Pubmed	Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points.	SEMA6A PLXNA2	9.83e-05	7	76	2	19063725
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	FAT4 FAT3	9.83e-05	7	76	2	22510986
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT4 FAT3	9.83e-05	7	76	2	16059920
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	CADM3 SEMA6A PLXNA2 PLXNB3	1.29e-04	117	76	4	17145500
Pubmed	The expression of plexins during mouse embryogenesis.	PLXNA2 PLXNB3	1.31e-04	8	76	2	15661641
Pubmed	A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability.	TELO2 ATM	1.31e-04	8	76	2	20810650
Pubmed	Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene.	TMEM169 FN1	1.31e-04	8	76	2	20463177
Pubmed	Essential roles of Meltrin beta (ADAM19) in heart development.	NRG1 FN1	1.31e-04	8	76	2	14975714
Pubmed	Evolutionarily conserved regulators of tau identify targets for new therapies.	UBE4A NOMO2 FGFR3 RAB6B RAB6A NOMO3 NOMO1	1.37e-04	516	76	7	36610398
Pubmed	Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.	FAT4 FN1	1.68e-04	9	76	2	28705793
Pubmed	Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2.	TELO2 ATM	1.68e-04	9	76	2	24657168
Pubmed	Expression of mRNA and protein-protein interaction of the antiviral endoribonuclease RNase L in mouse spleen.	FN1 MYBPC1	1.68e-04	9	76	2	24780566
Pubmed	Semaphorin 6A in Retinal Ganglion Cells Regulates Functional Specialization of the Inner Retina.	SEMA6A PLXNA2	1.68e-04	9	76	2	38014224
Pubmed	Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.	SEMA6A FGFR3 PLXNA2 PLXNB3	1.72e-04	126	76	4	16284245
Pubmed	An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.	SEMA6A PLXNA2 PLXNB3	2.05e-04	52	76	3	26633812
Pubmed	ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer.	OGT BRD4	2.10e-04	10	76	2	32669118
Pubmed	Tel2 regulates the stability of PI3K-related protein kinases.	TELO2 ATM	2.10e-04	10	76	2	18160036
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL12A1 FN1 COL6A6 AEBP1	2.24e-04	135	76	4	28675934
Pubmed	Characterization of cDNA clones in size-fractionated cDNA libraries from human brain.	KIF21B RPRD2 PLXNA2	2.56e-04	56	76	3	9455484
Pubmed	Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.	TELO2 ATM	2.56e-04	11	76	2	20427287
Pubmed	On and off retinal circuit assembly by divergent molecular mechanisms.	SEMA6A PLXNA2	3.07e-04	12	76	2	24179230
Pubmed	Ran binding protein 9 interacts with Raf kinase but does not contribute to downstream ERK1/2 activation in skeletal myoblasts.	FYCO1 MYBPC1	3.07e-04	12	76	2	16364241
Pubmed	RAB6 and dynein drive post-Golgi apical transport to prevent neuronal progenitor delamination.	RAB6B RAB6A	3.07e-04	12	76	2	35979738
Pubmed	Molecular diversity of myofibrillar proteins: gene regulation and functional significance.	MYOM1 MYBPC1	3.07e-04	12	76	2	8618961
Pubmed	Functional assembly of accessory optic system circuitry critical for compensatory eye movements.	SEMA6A PLXNA2	3.62e-04	13	76	2	25959730
Pubmed	Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.	PLXNA2 PLXNB3	3.62e-04	13	76	2	10520995
Pubmed	A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.	KCND3 FGFR3	3.62e-04	13	76	2	34666996
Pubmed	TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF.	SRSF2 MYBPC1	3.62e-04	13	76	2	16052631
Pubmed	A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins).	SRSF2 SRSF8	3.62e-04	13	76	2	20516191
Pubmed	Transmembrane insertases and N-glycosylation critically determine synthesis, trafficking, and activity of the nonselective cation channel TRPC6.	NOMO2 NOMO3 NOMO1	3.62e-04	63	76	3	31266804
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	FRAS1 FN1 COL20A1	3.80e-04	64	76	3	22261194
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	KIF21B SRSF2 NCKAP1 GNAL ARHGEF2 RAB6B RAB6A	4.22e-04	621	76	7	22794259
Pubmed	Identification and characterization of multiple novel Rab-myosin Va interactions.	RAB6B RAB6A	4.22e-04	14	76	2	24006491
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	IGSF10 CADM3 MFAP3 PRTG	4.48e-04	162	76	4	25826454
Pubmed	Sprouty1 haploinsufficiency prevents renal agenesis in a model of Fraser syndrome.	FRAS1 FN1	4.86e-04	15	76	2	23064016
Pubmed	Cytoplasmic control of Rab family small GTPases through BAG6.	RAB6B RAB6A	4.86e-04	15	76	2	30804014
Pubmed	CK2 phospho-dependent binding of R2TP complex to TEL2 is essential for mTOR and SMG1 stability.	TELO2 ATM	4.86e-04	15	76	2	20864032
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	BRD4 FGFR3 ATM	5.15e-04	71	76	3	28319113
Pubmed	Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival.	FN1 NCKAP1	5.54e-04	16	76	2	21945075
Pubmed	Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing.	SEMA6A PLXNA2	5.54e-04	16	76	2	22632726
Pubmed	A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.	FGFR3 TACC3	5.54e-04	16	76	2	20972438
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL12A1 FN1 COL6A6 PLXNA2	5.99e-04	175	76	4	28071719
Pubmed	Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections.	PLXNA2 PLXNB3	6.27e-04	17	76	2	11683995
Pubmed	Semaphorin signaling facilitates cleft formation in the developing salivary gland.	PLXNA2 PLXNB3	6.27e-04	17	76	2	17626059
Pubmed	Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.	FGFR3 PRG4	6.27e-04	17	76	2	22843502
Pubmed	The early topography of thalamocortical projections is shifted in Ebf1 and Dlx1/2 mutant mice.	SEMA6A FGFR3	7.05e-04	18	76	2	12421703
Pubmed	Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.	FAT4 FAT3	7.05e-04	18	76	2	33108146
Pubmed	BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation.	RAB6B RAB6A	7.05e-04	18	76	2	31588230
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KIF21B NRG1 FN1 NCKAP1 COL6A6 ATM	7.76e-04	497	76	6	36774506
Pubmed	Creb5 coordinates synovial joint formation with the genesis of articular cartilage.	FAT4 PRG4	7.87e-04	19	76	2	36435829
Pubmed	Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth.	MTTP FGFR3	7.87e-04	19	76	2	37541847
Interaction	LGALS1 interactions	ICOSLG PRTG FAT4 FRAS1 DET1 FN1 FAT3 BRD4 MUC16 PLXNA2	4.69e-07	332	76	10	int:LGALS1
Interaction	RYK interactions	MFAP3 PRTG FAT4 NCKAP1 FAT3 PLD1 PLXNA2 NOMO3	1.34e-06	212	76	8	int:RYK
Interaction	BAG6 interactions	KIF21B UBE4A SRSF2 FN1 BRD4 ATM RAB6B RAB6A NOMO3 NOMO1	7.13e-06	450	76	10	int:BAG6
Interaction	RNF130 interactions	UBE4A NRG1 NOMO2 FGFR3 RAB6B RAB6A NOMO3 NOMO1	3.05e-05	325	76	8	int:RNF130
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGSF10 NRG1 MFAP3 PRTG MYOM1 FGFR3 MYBPC1	2.11e-07	161	48	7	593
GeneFamily	Fibronectin type III domain containing	PRTG COL12A1 FN1 MYOM1 COL20A1 MYBPC1	3.95e-06	160	48	6	555
GeneFamily	CD molecules\|Mucins	MUC17 MUC16 MUC3A	2.26e-05	21	48	3	648
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYOM1 MYBPC1	1.91e-04	8	48	2	658
GeneFamily	Plexins	PLXNA2 PLXNB3	2.46e-04	9	48	2	683
GeneFamily	Collagens	COL12A1 COL6A6 COL20A1	2.46e-04	46	48	3	490
GeneFamily	RNA binding motif containing\|Serine and arginine rich splicing factors	SRSF2 SRSF8	4.48e-04	12	48	2	737
GeneFamily	Cadherin related	FAT4 FAT3	9.15e-04	17	48	2	24
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	CADM3 ICOSLG	5.05e-03	40	48	2	592
GeneFamily	Clustered protocadherins	PCDHGB6 PCDHGB3	1.25e-02	64	48	2	20
GeneFamily	RAB, member RAS oncogene GTPases	RAB6B RAB6A	1.29e-02	65	48	2	388
Coexpression	NABA_MATRISOME	IGSF10 NRG1 MFAP3 FRAS1 COL12A1 FN1 COL6A6 AEBP1 MUC17 COL20A1 MUC16 SEMA6A PRG4 MUC3A PLXNA2 PLXNB3	3.22e-08	1026	76	16	M5889
Coexpression	NABA_CORE_MATRISOME	IGSF10 MFAP3 FRAS1 COL12A1 FN1 COL6A6 AEBP1 COL20A1 PRG4	8.92e-08	270	76	9	MM17057
Coexpression	NABA_CORE_MATRISOME	IGSF10 MFAP3 FRAS1 COL12A1 FN1 COL6A6 AEBP1 COL20A1 PRG4	1.04e-07	275	76	9	M5884
Coexpression	NABA_MATRISOME	IGSF10 NRG1 MFAP3 FRAS1 COL12A1 FN1 COL6A6 AEBP1 MUC17 COL20A1 MUC16 SEMA6A PRG4 PLXNA2 PLXNB3	1.70e-07	1008	76	15	MM17056
Coexpression	GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	OGT NCKAP1 MTTP PLD1 ARHGEF2 RAB6B CHRNB1	1.90e-06	200	76	7	M5276
Coexpression	ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	OR10J5 PCDHGB6 PCDHGB3 NOMO2 PRG4 NOMO3 NOMO1	3.79e-06	222	76	7	M16955
Coexpression	NABA_ECM_AFFILIATED	MUC17 MUC16 SEMA6A MUC3A PLXNA2 PLXNB3	1.02e-05	170	76	6	M5880
Coexpression	KORKOLA_YOLK_SAC_TUMOR	NRG1 PRTG FRAS1 PLXNA2	3.86e-05	65	76	4	M6250
Coexpression	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	COL12A1 FN1 AEBP1 TACC3	6.44e-05	74	76	4	M13547
Coexpression	NABA_ECM_AFFILIATED	MUC17 MUC16 SEMA6A PLXNA2 PLXNB3	9.77e-05	158	76	5	MM17063
Coexpression	KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	GPRASP1 AEBP1 SRSF8 ATM MYBPC1 NOMO1	1.01e-04	256	76	6	M10952
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	IGSF10 FAT4 FRAS1 COL6A6 AEBP1 FAT3 PRG4	5.21e-08	200	76	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGSF10 FAT4 FRAS1 COL6A6 AEBP1 FAT3 PRG4	5.21e-08	200	76	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGSF10 FAT4 FRAS1 COL6A6 AEBP1 FAT3 PRG4	5.21e-08	200	76	7	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRTG TMPRSS13 AEBP1 FAT3 FGFR3 CHRNB1	5.36e-07	174	76	6	a0ccda8fd6f55251cdeff24cf66e72e4a31d2104
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE IGSF10 FN1 COL6A6 AEBP1 FAT3	9.53e-07	192	76	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	TRHDE FAT4 FRAS1 FN1 COL6A6 FAT3	9.82e-07	193	76	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE IGSF10 FN1 COL6A6 AEBP1 FAT3	1.01e-06	194	76	6	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.01e-06	194	76	6	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.04e-06	195	76	6	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.04e-06	195	76	6	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.07e-06	196	76	6	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.07e-06	196	76	6	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.07e-06	196	76	6	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 FAT4 FN1 COL6A6 AEBP1 PRG4	1.11e-06	197	76	6	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.11e-06	197	76	6	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.14e-06	198	76	6	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGSF10 FRAS1 FN1 COL6A6 AEBP1 PRG4	1.17e-06	199	76	6	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGSF10 FN1 COL6A6 AEBP1 FAT3 PRG4	1.17e-06	199	76	6	66a79732caf2f04c09b4d9832377aa01ca477677
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CADM3 FAT4 COL12A1 FN1 AEBP1 PRG4	1.21e-06	200	76	6	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGSF10 FRAS1 COL6A6 AEBP1 FAT3 PRG4	1.21e-06	200	76	6	8c62f05c6042f24287a73fbdf80ff4a56f7ff403
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CADM3 FAT4 COL12A1 FN1 AEBP1 PRG4	1.21e-06	200	76	6	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	IGSF10 CADM3 COL12A1 FN1 AEBP1 PRG4	1.21e-06	200	76	6	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE FAT4 FN1 COL6A6 AEBP1 FAT3	1.21e-06	200	76	6	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE FRAS1 FN1 COL6A6 AEBP1 FAT3	1.21e-06	200	76	6	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE FRAS1 TMEM169 COL12A1 FAT3	8.05e-06	160	76	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE FRAS1 TMEM169 COL12A1 FAT3	8.05e-06	160	76	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 COL6A6 AEBP1 MUC16 PRG4	9.91e-06	167	76	5	c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRAS1 COL6A6 AEBP1 MUC16 PRG4	9.91e-06	167	76	5	351f8de1fbdf742ac74f9099b254d515ab539bb2
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	FN1 FAT3 SEMA6A FGFR3 PRG4	1.21e-05	174	76	5	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IGSF10 FAT4 COL12A1 FN1 AEBP1	1.28e-05	176	76	5	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IGSF10 FAT4 COL12A1 FN1 AEBP1	1.28e-05	176	76	5	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CADM3 FAT4 COL12A1 FN1 AEBP1	1.46e-05	181	76	5	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	metastatic_Brain-Fibroblasts-Myofibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	COL12A1 FN1 AEBP1 FAT3 PRG4	1.46e-05	181	76	5	bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IGSF10 FRAS1 FN1 COL6A6 FAT3	1.46e-05	181	76	5	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TRHDE FRAS1 KCND3 COL20A1 PLXNB3	1.46e-05	181	76	5	fad7ba168f541ac9d04edebc206f191e48bb7e99
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE FAT4 FRAS1 COL12A1 FAT3	1.58e-05	184	76	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE FAT4 FRAS1 COL12A1 FAT3	1.58e-05	184	76	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE FAT4 FRAS1 COL12A1 FAT3	1.58e-05	184	76	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	moderate-Lymphoid-NK\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PRTG FAT4 COL12A1 FN1 AEBP1	1.62e-05	185	76	5	4979a787acbc9b4ca8defe91cc79b674e51af1bf
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	CADM3 COL6A6 AEBP1 KCND3 GNAL	1.71e-05	187	76	5	e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	TRHDE FRAS1 FN1 COL6A6 FAT3	1.71e-05	187	76	5	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE IGSF10 COL6A6 AEBP1 FAT3	1.80e-05	189	76	5	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRAS1 CARMIL3 HS3ST5 SEMA6A NMBR	1.80e-05	189	76	5	f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRHDE IGSF10 FRAS1 FN1 FAT3	1.80e-05	189	76	5	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	moderate-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PRTG FAT4 COL12A1 FN1 AEBP1	1.80e-05	189	76	5	22a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	FRAS1 FN1 COL6A6 FAT3 PRG4	1.85e-05	190	76	5	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE IGSF10 COL6A6 AEBP1 FAT3	1.85e-05	190	76	5	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 FN1 FAT3 FGFR3 MYBPC1	1.89e-05	191	76	5	cc9a6a8fad17d6e1a08a68ab7512ae06b1249051
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 FN1 FAT3 FGFR3 MYBPC1	1.89e-05	191	76	5	c16b920ee69ea8536e020ac3475abf1ce972c1e6
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE IGSF10 COL6A6 AEBP1 FAT3	1.94e-05	192	76	5	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 CADM3 FN1 AEBP1 PRG4	1.94e-05	192	76	5	853a930e0641ffb50cbb4cef5837c70d75c3fc39
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 COL12A1 COL6A6 AEBP1 PRG4	1.94e-05	192	76	5	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 CADM3 FN1 COL6A6 AEBP1	1.94e-05	192	76	5	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE IGSF10 COL6A6 AEBP1 FAT3	1.94e-05	192	76	5	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 CADM3 FN1 AEBP1 PRG4	1.94e-05	192	76	5	d2c03490c5e835d0f0a732803093c64b8d4b4029
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 CADM3 FN1 AEBP1 PRG4	1.94e-05	192	76	5	49281626ecad0456fdbded2378b7028d7b589686
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FRAS1 FN1 COL6A6 FAT3 PLXNA2	1.94e-05	192	76	5	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	TRHDE FN1 COL6A6 FAT3 PLXNA2	1.99e-05	193	76	5	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGSF10 CADM3 FAT4 COL12A1 AEBP1	2.09e-05	195	76	5	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 CADM3 COL12A1 FN1 AEBP1	2.09e-05	195	76	5	223f5f07dc28fa13a09bb589884c58043c7928c7
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	TRHDE FRAS1 FN1 COL6A6 FAT3	2.09e-05	195	76	5	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	15-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	FAT4 COL12A1 FN1 COL6A6 AEBP1	2.14e-05	196	76	5	7e178c76285e61c721c38d7a995ebf89dc428f9f
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 FN1 COL6A6 FAT3 PRG4	2.14e-05	196	76	5	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FRAS1 FN1 COL6A6 FAT3 PRG4	2.14e-05	196	76	5	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 CADM3 COL12A1 FN1 AEBP1	2.14e-05	196	76	5	f47e551ba484687ba6ce8c29a085106131364042
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IGSF10 FN1 COL6A6 AEBP1 FAT3	2.14e-05	196	76	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	FAT4 COL12A1 FN1 COL6A6 AEBP1	2.14e-05	196	76	5	54aefcebf13704f51de84379e2e22ec0734b9461
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE FAT4 FN1 COL6A6 AEBP1	2.20e-05	197	76	5	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	IGSF10 COL6A6 AEBP1 FAT3 PRG4	2.20e-05	197	76	5	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRTG COL12A1 FN1 FAT3 FGFR3	2.20e-05	197	76	5	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 COL12A1 FN1 FAT3 FGFR3	2.20e-05	197	76	5	63b63c6b2f842adb87bc83222ff86796bd9b58f6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	IGSF10 FRAS1 FN1 COL6A6 FAT3	2.20e-05	197	76	5	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 COL12A1 FN1 FAT3 FGFR3	2.20e-05	197	76	5	fb50903b87498b400c8e16e6a561b6d9458e5d97
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGSF10 COL6A6 AEBP1 FAT3 PRG4	2.25e-05	198	76	5	a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	FRAS1 FN1 FAT3 PRG4 PLXNA2	2.25e-05	198	76	5	e0e47cf65774191981840b22905b2094b95abe0f
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	FRAS1 FN1 COL6A6 AEBP1 KCND3	2.25e-05	198	76	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGSF10 COL6A6 AEBP1 FAT3 PRG4	2.25e-05	198	76	5	7b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGSF10 FN1 COL6A6 FAT3 PRG4	2.30e-05	199	76	5	7f4840ae6a888380feca722543e5e52783f3e35d
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRTG COL12A1 FN1 FAT3 FGFR3	2.30e-05	199	76	5	d65ee89d5c7e8ed693d58e6a6de09565840e11c5
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	FAT4 FRAS1 COL12A1 FN1 FAT3	2.30e-05	199	76	5	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	proximal-3-mesenchymal-Alveolar_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGSF10 FN1 COL6A6 FAT3 PRG4	2.30e-05	199	76	5	301d02bbb37e6f1d24b6e865bc3fe3e91260eb30
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	FAT4 FN1 COL6A6 AEBP1 FAT3	2.30e-05	199	76	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	proximal-mesenchymal-Alveolar_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGSF10 FN1 COL6A6 FAT3 PRG4	2.30e-05	199	76	5	9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGSF10 FN1 COL6A6 AEBP1 PRG4	2.30e-05	199	76	5	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NRG1 DLG5 MUC16 FGFR3 PLD1	2.30e-05	199	76	5	f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	IGSF10 FN1 COL6A6 AEBP1 PRG4	2.30e-05	199	76	5	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRTG COL12A1 FN1 FAT3 FGFR3	2.30e-05	199	76	5	bf138cc692df727e087d140c014149ee5da00d9d
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IGSF10 FRAS1 FN1 COL6A6 PRG4	2.30e-05	199	76	5	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IGSF10 FRAS1 FN1 COL6A6 PRG4	2.30e-05	199	76	5	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	cellseq-Mesenchymal-Fibroblastic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGSF10 FN1 COL6A6 AEBP1 PRG4	2.36e-05	200	76	5	8978867bf69c830b1e48cac2ad6b512dbe60f149
ToppCell	medial-mesenchymal-Alveolar_Fibroblast\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGSF10 FRAS1 FN1 COL6A6 AEBP1	2.36e-05	200	76	5	c22cbfecee00183dd4be678f116ab9fd9ad0a4dd
ToppCell	5'-Adult-SmallIntestine-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGSF10 CADM3 COL12A1 FN1 AEBP1	2.36e-05	200	76	5	a637281d91e95734ee4f8510b3780e0272b16fda
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE FN1 COL6A6 AEBP1 FAT3	2.36e-05	200	76	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE FRAS1 FN1 COL6A6 FAT3	2.36e-05	200	76	5	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 COL12A1 FN1 COL6A6 AEBP1	2.36e-05	200	76	5	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGSF10 CADM3 COL12A1 FN1 AEBP1	2.36e-05	200	76	5	6f7f015b5fa1f52374f2c7d9ba339012395eda5f
ToppCell	medial-2-mesenchymal-Alveolar_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGSF10 FRAS1 FN1 COL6A6 AEBP1	2.36e-05	200	76	5	cc6062dac07916c29091fc6bee2b864d29e6525b
ToppCell	medial-mesenchymal-Alveolar_Fibroblast-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IGSF10 FRAS1 FN1 COL6A6 AEBP1	2.36e-05	200	76	5	5c0716bf375c8158f7dc2c82bf5eaf37af594dd0
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE FN1 COL6A6 AEBP1 FAT3	2.36e-05	200	76	5	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGSF10 CADM3 COL12A1 FN1 AEBP1	2.36e-05	200	76	5	3a164e3971bcd62b148b813171c103adb81f972e
Computational	Genes in the cancer module 387.	MYOM1 AEBP1 CHRNB1 MYBPC1	7.52e-05	49	50	4	MODULE_387
Computational	Genes in the cancer module 329.	MYOM1 AEBP1 CHRNB1 MYBPC1	8.81e-05	51	50	4	MODULE_329
Drug	Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; PC3; HT_HG-U133A	KIF21B CADM3 NRG1 FN1 PCDHGB6 SEMA6A GNAL	4.60e-06	199	76	7	4188_UP
Drug	Quercetine dihydrate [6151-25-3]; Up 200; 11.8uM; PC3; HT_HG-U133A	NRG1 ICOSLG PCDHGB6 KCND3 SEMA6A GNAL PLXNA2	4.76e-06	200	76	7	4264_UP
Disease	Giant Cell Glioblastoma	FN1 BRD4 FGFR3 TACC3	5.73e-05	84	73	4	C0334588
Disease	fibroblast growth factor receptor 3 measurement	FGFR3 TACC3	6.01e-05	5	73	2	EFO_0020390
Disease	retinal detachment, retinal break	DLG5 FRAS1 FAT3	8.98e-05	35	73	3	EFO_0005773, EFO_0010698
Disease	Congenital cataract	TDRD7 FYCO1	9.00e-05	6	73	2	C0009691
Disease	inferior temporal gyrus volume measurement	FGFR3 TACC3	3.27e-04	11	73	2	EFO_0010308
Disease	Charcot-Marie-Tooth disease (is_implicated_in)	CADM3 NRG1	3.92e-04	12	73	2	DOID:10595 (is_implicated_in)
Disease	Neoplasm of uncertain or unknown behavior of bladder	FGFR3 ATM	6.21e-04	15	73	2	C0496930
Disease	Benign neoplasm of bladder	FGFR3 ATM	6.21e-04	15	73	2	C0154017
Disease	Carcinoma in situ of bladder	FGFR3 ATM	6.21e-04	15	73	2	C0154091
Disease	gliosarcoma	FGFR3 TACC3	7.08e-04	16	73	2	C0206726
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB6 PCDHGB3 NOMO2	7.36e-04	71	73	3	EFO_0007878, EFO_0007979
Disease	Carcinoma of bladder	FGFR3 ATM	9.00e-04	18	73	2	C0699885
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	FGFR3 TACC3	1.23e-03	21	73	2	EFO_0004616, EFO_0010726, EFO_1000786
Disease	Lymphoma, T-Cell, Cutaneous	FGFR3 ATM	1.48e-03	23	73	2	C0079773
Disease	Pseudoaphakia	TDRD7 ATM	1.61e-03	24	73	2	C0524524
Disease	Lens Opacities	TDRD7 ATM	1.61e-03	24	73	2	C1510497
Disease	Squamous cell carcinoma of esophagus	FAT4 RNF6 FAT3	1.71e-03	95	73	3	C0279626
Disease	mental development measurement	PCDHGB6 PCDHGB3	1.75e-03	25	73	2	EFO_0008230
Disease	Hyperplasia	BRD4 PRG4	2.19e-03	28	73	2	C0020507
Disease	hormone measurement, thyroid stimulating hormone measurement	NRG1 DET1	2.35e-03	29	73	2	EFO_0004730, EFO_0004748
Disease	brain measurement, neuroimaging measurement	KIF21B PRTG FAT3 GALNT12 FGFR3 TACC3	2.42e-03	550	73	6	EFO_0004346, EFO_0004464

Protein segments in the cluster

Peptide	Gene	Start	Entry
EQRILLDPSVSSISY	TRHDE	416	Q9UKU6
PSTLRELERYVTSCL	BRD4	661	O60885
ERYLSPDATVSTEVR	AEBP1	731	Q8IUX7
RSKTTIRERPSSAIY	ARHGEF2	111	Q92974
VLVSPTSEQYDSLLR	GTPBP1	66	O00178
YTTSTIDRESLPSDV	FAT4	91	Q6V0I7
PELREVVSSISYIAR	CHRNB1	431	P11230
SSRYIGIPTSTSEII	BIVM	106	Q86UB2
TSIRYVTPRALSDPE	DEDD	121	O75618
RSTSQRIEVLYTPTA	CADM3	221	Q8N126
YTSEDVVTLRVTDPS	DET1	346	Q7L5Y6
IHYLDTTTLIEPVSR	CRK	106	P46108
YDTSSPSILTLTAIR	NOMO3	651	P69849
RSLIPSYIRDSTVAV	RAB6A	76	P20340
RSLIPSYIRDSTVAV	RAB6B	76	Q9NRW1
AYVSSESPIRISVST	NRG1	146	Q02297
PLSSSRSITLYVADI	PCDHGB6	431	Q9Y5F9
YFLTPRLRETSTSQE	MUC16	5186	Q8WXI7
LSTLTSRVPEYISGT	MUC16	6486	Q8WXI7
YDTSSPSILTLTAIR	NOMO2	651	Q5JPE7
YLVDDPLLSVRTSTI	KCND3	491	Q9UK17
TTTELVIRCVIPSLY	NMBR	36	P28336
RISTYSTIAIPSIEA	NT5DC1	401	Q5TFE4
PITRSGDLSYESSVR	FRAS1	2936	Q86XX4
ELFVRSSTYSLIPIT	FYCO1	1366	Q9BQS8
EPRYALTTTLSARVA	MYG1	186	Q9HB07
VLEESSSYPRTLRTV	CARMIL3	1021	Q8ND23
IVREPTTRAISDYTQ	HS3ST5	181	Q8IZT8
STPVEGLTLYTTSRD	PLXNA2	416	O75051
EPSLYRTSARIVCVT	PLXNB3	881	Q9ULL4
IERSPRSASTYSLDI	MTTP	621	P55157
ITITRSTLTSETAYP	MUC3A	1451	Q02505
IRTYDNSIPISESSR	CYLC1	11	P35663
ATETSPLTRRKSYDR	KIF21B	1211	O75037
YDTSSPSILTLTAIR	NOMO1	651	Q15155
TTVSSILRNPIYTVR	DLG5	1186	Q8TDM6
LEPRELSSYVSVSAR	PCDHGB3	496	Q9Y5G1
TFTPREYLTSHLEIR	NCKAP1	701	Q9Y2A7
VTSPIRASYSVTLRV	MFAP3	126	P55082
PETVVTRYTILYASR	PRTG	846	Q2VWP7
DIYLDTPSSGTRRVS	PPP1R3A	51	Q16821
LYDVVSVLRIARTPS	ICOSLG	196	O75144
LERIDSVSLVDYTPT	GNAL	166	P38405
SETEYALLRTSVSRP	GCSAML	106	Q5JQS6
LVTYDLETAIPSSTR	ATM	2046	Q13315
PASVITYETQTERSR	IGSF10	1326	Q6WRI0
TVRNLRVYDPSTSTL	COL12A1	1846	Q99715
RSDPVSLRYTPSTVS	COL20A1	726	Q9P218
ERSTTPDITGYRITT	FN1	1196	P02751
TTYSVTIAESTPLRT	FAT3	161	Q8TDW7
TLLRTVYSVLETSPD	GALNT12	151	Q8IXK2
SIRQTYTLDVLERSP	FGFR3	236	P22607
YRIETRVSSSCLDLP	RPRD2	1061	Q5VT52
REIETIPYERSSASR	COL6A6	1826	A6NMZ7
EEVPRTIIVTTRSQY	OGT	821	O15294
LASSETVYTLVIVPR	OR10J5	66	Q8NHC4
LSTTLADTRTPVTTY	MUC17	1946	Q685J3
IETLLNYPSSRVRTS	GPRASP1	1201	Q5JY77
LPERYSSLETSRLTI	PGGT1B	36	P53609
LTYRTSPDTLRRVFE	SRSF2	21	Q01130
LSSYSLDRRVTPASE	TACC3	186	Q9Y6A5
PTSIDESSSVVLRYR	FAM78A	51	Q5JUQ0
LEVERFTSTTRVPSI	PLD1	86	Q13393
YVSTITVPLRRISEN	RNF6	456	Q9Y252
LVYRSPTATREVSVE	TELO2	541	Q9Y4R8
PEELRTALTTTISSR	MRI1	346	Q9BV20
AYLRSVPAVVRIETS	TDRD7	51	Q8NHU6
LTYRTSPDSLRRVFE	SRSF8	21	Q9BRL6
YNIDVPSRTARAITT	PRG4	1376	Q92954
RTLPRSITYVSIIIF	CLN6	106	Q9NWW5
SVTTSPTRVYLVRAT	TMPRSS13	111	Q9BYE2
VIYRSLGESPTLRTV	SEMA6A	196	Q9H2E6
LLYVVIPTRRSTAEA	SPNS1	406	Q9H2V7
ERLTDVYSTSPSLGR	TTMP	131	Q5BVD1
TVSNTRTVLLTPEIY	UBE4A	206	Q14139
PLDSRYVTLTGTITR	TMEM169	96	Q96HH4
PTDLSVTEATRSYVV	MYOM1	641	P52179
GRIRTESYPDSSTLV	MYBPC1	571	Q00872